Effects of OG-VI, a nucleoside-nucleotide mixture, on ischemic myocardial metabolism in dogs. 1997

Y Okazaki, and S Kano, and S Ogoshi, and K Ichihara
Department of Surgery II, Kochi Medical School, Nankoku, Japan.

BACKGROUND OG-VI is a solution composed of 30 mmol/l inosine, 30 mmol/l sodium 5'-guanylate, 30 mmol/l cytidine, 22.5 mmol/l uridine, and 7.5 mmol/l thymidine, which is known to improve myocardial stunning. OBJECTIVE To study the effect of OG-VI on myocardial energy and carbohydrate metabolism during ischemia. METHODS Ischemia was induced in pentobarbital-anesthetized open-chested dogs for 3 min by left anterior descending coronary artery ligation. Saline, 1.2 mmol/kg per min OG-VI, or 12 mmol/kg per min OG-VI was infused at 0.1 ml/kg per min, starting 30 min before the onset of ischemia. The myocardium was extracted 3 min after the onset of ischemia, and used to determine the tissue levels of energy and carbohydrate metabolites. RESULTS Ischemia decreased the levels of ATP and fructose 1,6 diphosphate significantly, and increased those of AMP, glucose 6 phosphate, fructose 6 phosphate and lactate. OG-VI infusion preserved the adenine nucleotide levels significantly in 3 min ischemic hearts, and attenuated the ischemia-induced alteration of carbohydrate metabolism. CONCLUSIONS OG-VI may improve the myocardial metabolic derangement induced by ischemia.

UI MeSH Term Description Entries
D008297 Male Males
D009206 Myocardium The muscle tissue of the HEART. It is composed of striated, involuntary muscle cells (MYOCYTES, CARDIAC) connected to form the contractile pump to generate blood flow. Muscle, Cardiac,Muscle, Heart,Cardiac Muscle,Myocardia,Cardiac Muscles,Heart Muscle,Heart Muscles,Muscles, Cardiac,Muscles, Heart
D009705 Nucleosides Purine or pyrimidine bases attached to a ribose or deoxyribose. (From King & Stansfield, A Dictionary of Genetics, 4th ed) Nucleoside,Nucleoside Analog,Nucleoside Analogs,Analog, Nucleoside,Analogs, Nucleoside
D009711 Nucleotides The monomeric units from which DNA or RNA polymers are constructed. They consist of a purine or pyrimidine base, a pentose sugar, and a phosphate group. (From King & Stansfield, A Dictionary of Genetics, 4th ed) Nucleotide
D010710 Phosphates Inorganic salts of phosphoric acid. Inorganic Phosphate,Phosphates, Inorganic,Inorganic Phosphates,Orthophosphate,Phosphate,Phosphate, Inorganic
D002316 Cardiotonic Agents Agents that have a strengthening effect on the heart or that can increase cardiac output. They may be CARDIAC GLYCOSIDES; SYMPATHOMIMETICS; or other drugs. They are used after MYOCARDIAL INFARCT; CARDIAC SURGICAL PROCEDURES; in SHOCK; or in congestive heart failure (HEART FAILURE). Cardiac Stimulant,Cardiac Stimulants,Cardioprotective Agent,Cardioprotective Agents,Cardiotonic,Cardiotonic Agent,Cardiotonic Drug,Inotropic Agents, Positive Cardiac,Myocardial Stimulant,Myocardial Stimulants,Cardiotonic Drugs,Cardiotonics,Agent, Cardioprotective,Agent, Cardiotonic,Drug, Cardiotonic,Stimulant, Cardiac,Stimulant, Myocardial
D004285 Dogs The domestic dog, Canis familiaris, comprising about 400 breeds, of the carnivore family CANIDAE. They are worldwide in distribution and live in association with people. (Walker's Mammals of the World, 5th ed, p1065) Canis familiaris,Dog
D004734 Energy Metabolism The chemical reactions involved in the production and utilization of various forms of energy in cells. Bioenergetics,Energy Expenditure,Bioenergetic,Energy Expenditures,Energy Metabolisms,Expenditure, Energy,Expenditures, Energy,Metabolism, Energy,Metabolisms, Energy
D005260 Female Females
D006439 Hemodynamics The movement and the forces involved in the movement of the blood through the CARDIOVASCULAR SYSTEM. Hemodynamic

Related Publications

Y Okazaki, and S Kano, and S Ogoshi, and K Ichihara
October 1995, Coronary artery disease,
Y Okazaki, and S Kano, and S Ogoshi, and K Ichihara
January 1998, Coronary artery disease,
Y Okazaki, and S Kano, and S Ogoshi, and K Ichihara
April 1997, Nutrition (Burbank, Los Angeles County, Calif.),
Y Okazaki, and S Kano, and S Ogoshi, and K Ichihara
November 1993, Coronary artery disease,
Y Okazaki, and S Kano, and S Ogoshi, and K Ichihara
October 1988, Nihon Geka Gakkai zasshi,
Y Okazaki, and S Kano, and S Ogoshi, and K Ichihara
August 2007, The journal of medical investigation : JMI,
Y Okazaki, and S Kano, and S Ogoshi, and K Ichihara
August 1994, European journal of pharmacology,
Y Okazaki, and S Kano, and S Ogoshi, and K Ichihara
April 1993, Journal of pharmaceutical sciences,
Y Okazaki, and S Kano, and S Ogoshi, and K Ichihara
May 2001, Nihon rinsho. Japanese journal of clinical medicine,
Copied contents to your clipboard!